IBDEI15E ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18457,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,18457,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,18457,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,18458,0)
 ;;=G30.0^^91^938^2
 ;;^UTILITY(U,$J,358.3,18458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18458,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,18458,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,18458,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,18459,0)
 ;;=G30.1^^91^938^3
 ;;^UTILITY(U,$J,358.3,18459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18459,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,18459,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,18459,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,18460,0)
 ;;=B20.^^91^938^21
 ;;^UTILITY(U,$J,358.3,18460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18460,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,18460,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,18460,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,18461,0)
 ;;=G10.^^91^938^22
 ;;^UTILITY(U,$J,358.3,18461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18461,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,18461,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,18461,2)
 ;;=^5003751
 ;;^UTILITY(U,$J,358.3,18462,0)
 ;;=G30.8^^91^938^1
 ;;^UTILITY(U,$J,358.3,18462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18462,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,18462,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,18462,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,18463,0)
 ;;=A81.89^^91^938^5
 ;;^UTILITY(U,$J,358.3,18463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18463,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,18463,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,18463,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,18464,0)
 ;;=G20.^^91^938^26
 ;;^UTILITY(U,$J,358.3,18464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18464,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,18464,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,18464,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,18465,0)
 ;;=G23.1^^91^938^30
 ;;^UTILITY(U,$J,358.3,18465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18465,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,18465,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,18465,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,18466,0)
 ;;=F03.91^^91^938^16
 ;;^UTILITY(U,$J,358.3,18466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18466,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,18466,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,18466,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,18467,0)
 ;;=F03.90^^91^938^18
 ;;^UTILITY(U,$J,358.3,18467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18467,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,18467,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,18467,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,18468,0)
 ;;=G31.84^^91^938^23
 ;;^UTILITY(U,$J,358.3,18468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18468,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,18468,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,18468,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,18469,0)
 ;;=F02.81^^91^938^14
 ;;^UTILITY(U,$J,358.3,18469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18469,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/ Behav Dist
